NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it will supply Quest Diagnostics with its BioPlex 2200 systems and autoimmune test reagents, as well as its HIV-1/HIV-2 PLUS O EIA assay for use in its reference laboratories nationwide.
 
Terms of the agreements were not released.
 
In early April Bio-Rad announced that it had released Epstein Barr virus kits to run on the BioPlex 2200 system and that it has more than 15 other multiplex reagent kits in development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.